Viewing StudyNCT00134667

Home Icon Home Search Icon Search Alerts Icon Stocks Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs eRecord Icon eRecord
Main Search All Studies All Organizations Report Bug
View Study With Definitions
Ignite Creation Date: 2024-05-05 @ 11:47 AM
Last Modification Date: 2024-10-26 @ 9:13 AM
Study NCT ID: NCT00134667
Status: TERMINATED
Last Update Posted: 2007-01-15
First Post: 2005-08-24
Brief Title: Macugen Pegaptanib Sodium Alone Versus Macugen in Combination With PDT Photodynamic Therapy With Visudyne Verteporfin in Patients With Age-Related Macular Degeneration AMD
Sponsor: Eyetech Pharmaceuticals
Organization: Eyetech Pharmaceuticals
Overview Dates Organization Conditions Design Enrollment Locations Outcomes

Conditions & Keywords Data

Conditions:
Name
Age-Related Macular Degeneration
Keywords:
Name View
Age-Related Macular Degeneration AMD View
AMD View
Age-Related Macular Degeneration View
Macular Degeneration View
Macugen View
Photodynamic Therapy View
PDT View
Visudyne View
pegaptanib sodium View
verteporfin View
Predominantly Classic View